PART I U.K. GENERAL RULES

CHAPTER 2 U.K. Listed diseases and emerging diseases and listed species

Article 7 U.K. Assessment parameters for the listing of diseases

The Commission shall use the following assessment parameters in order to determine whether a disease meets the conditions requiring it to be listed in accordance with Article 5(2):

(a)

the disease profile, which shall comprise the following:

(i)

the animal species concerned by the disease;

(ii)

the morbidity and mortality rates of the disease in animal populations;

(iii)

the zoonotic character of the disease;

(iv)

the resistance to treatments, including antimicrobial resistance;

(v)

the persistence of the disease in an animal population or in the environment;

(vi)

the routes and speed of transmission of the disease between animals and, when relevant, between animals and humans;

(vii)

the absence or presence and distribution of the disease in the Union, and, where the disease is not present in the Union, the risk of its introduction into the Union;

(viii)

the existence of diagnostic and disease control tools;

(b)

the impact of the disease on:

(i)

agricultural and aquaculture production and other parts of the economy, as regards:

• the level of presence of the disease in the Union;

• the loss of production due to the disease;

• other losses;

(ii)

human health, as regards:

• transmissibility between animals and humans;

• transmissibility between humans;

• the severity of human forms of the disease;

• the availability of effective prevention or medical treatment in humans;

(iii)

animal welfare;

(iv)

biodiversity and the environment;

(c)

its potential to generate a crisis situation and its potential use in bioterrorism;

(d)

the feasibility, availability and effectiveness of the following disease prevention and control measures:

(i)

diagnostic tools and capacities;

(ii)

vaccination;

(iii)

medical treatments;

(iv)

biosecurity measures;

(v)

restrictions on the movement of animals and products;

(vi)

killing of animals;

(vii)

disposal of carcasses and other relevant animal by–products;

(e)

the impact of disease prevention and control measures, as regards:

(i)

the direct and indirect costs for the affected sectors and the economy as a whole;

(ii)

their societal acceptance;

(iii)

the welfare of affected subpopulations of kept and wild animals;

(iv)

the environment and biodiversity.